v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating Expenses:    
Research and development expenses $ 2,557 $ 3,052
Selling, general and administrative expenses 2,397 2,451
Loss from Operations (4,954) (5,503)
Other Income:    
Realized gain from sales of trading securities 426 408
Unrealized gain (loss) from trading securities (194) 44
Interest income, net 219 59
Total Other Income 451 511
Net Loss $ (4,503) $ (4,992)
Net Loss Per Basic Common Share $ (0.22) $ (0.31)
Net Loss Per Diluted Common Share $ (0.22) $ (0.31)
Weighted Average Number of Common Shares Outstanding:    
Basic 20,352 16,057
Diluted 20,352 16,057